AMANDA GIBBONS: Open Payments
NPI 1235546490 · CASSVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 20 payments from 17 companies in 2025. Trend: 2023 $41 · 2024 $261 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Mindray DS USA, Inc. | 1 | $32 |
| Exact Sciences Corporation | 2 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: Ozempic, REXULTI, JARDIANCE, A7 ANESTHESIA SYSTEM, Veozah, ZENPEP, BREZTRI, UBRELVY.
Industry payments across MO — which companies pay providers there.
